FULC
Fulcrum Therapeutics, Inc. · Healthcare
Ra Capital Management, L.P. bought $13.1M of Fulcrum Therapeutics, Inc.
10% owner
Bought$13,073,874
$5.44Price
2,403,049Shares
+34%Stake
What FULC did for a copier
- $1,000 copied at Mon, Dec 19 open, $5.72
- $2,260
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Feb 2 close.
Ra Capital Management, L.P.'s record
63 other buys with 3 months of prices since 2016: on average +0.5% against the S&P 500, and 23 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 14. Filed Fri, Dec 16, 4:41 PM ET, after the close. Returns use the Dec 19 open and the Feb 2 close. Not investment advice.